Root Financial Partners
TCRX icon

Root Financial Partners’s TScan Therapeutics TCRX Stock Holding History

Root Financial Partners’s Portfolio TCRX Stock Details TCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$27 Buy
+85
New +$59 ﹤0.01% 3771

Other funds holding TCRX

Aries Wealth Management
Aries Wealth Management Portland, Maine $519M AUM 19.77% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Root Financial Partners's TCRX Position: Q3 2026 in Review

Root Financial Partners opened a new position in TScan Therapeutics (TCRX) in Q3 2026: 85 shares worth $27. The stake represents ﹤0.01% of the portfolio and ranks #3771 among its holdings.

3 funds tracked by Wall St. Rank hold TCRX as of Q3 2026.

  • Root Financial Partners held 85 shares of TScan Therapeutics worth $27 as of Q3 2026.
  • TScan Therapeutics was a new Root Financial Partners position in Q3 2026.
  • TScan Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3771 holding.
  • 3 funds tracked by Wall St. Rank held TScan Therapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.